文献速递脊柱关节炎

银屑病指趾炎与HLA遗传易感标志物的关联

Psoriatic dactylitis: the association with HLA genetic susceptibility markers.
PubMed 文献 · Ann Rheum Dis · 2026-03-05

该研究基于1216例银屑病关节炎(PsA)患者的观察性队列,分析HLA-B和HLA-C等位基因及单倍型与指趾炎风险的关联。结果显示HLA-B*27、HLA-C*02及HLA-B*27/C*02单倍型与指趾炎风险升高相关,HLA-B*15与风险降低相关;HLA-B*27还与压痛指趾炎消退更慢相关。

要点

  • HLA-B*27、HLA-C*02及HLA-B*27/C*02单倍型与PsA指趾炎风险升高相关。
  • HLA-B*15与指趾炎风险降低相关。
  • HLA-B*27与压痛指趾炎消退更慢相关。

核心结论

  • HLA-B*27、HLA-C*02及HLA-B*27/C*02单倍型与PsA指趾炎易感性相关,HLA-B*27还可能影响压痛指趾炎的消退。

研究设计与样本

  • 研究纳入1216例在观察性队列中随访的PsA患者,检索其纵向数据。
  • 对样本中频率>5%的HLA-B和HLA-C等位基因,采用广义估计方程拟合的logistic回归分析与指趾炎的关联,并分析常见单倍型。
  • 采用校正混杂因素的Cox回归分析这些等位基因和单倍型与首次压痛指趾炎消退时间的关联。

主要发现

  • 中位随访12.0年(IQR 5.7-20.1)期间,584例(48%)患者出现指趾炎。
  • HLA-B*27(OR 1.94,95%CI 1.49-2.53)、HLA-C*02(OR 1.63,95%CI 1.17-2.25)及HLA-B*27/C*02(OR 1.88,95%CI 1.32-2.67)与指趾炎风险升高相关。
  • HLA-B*15与指趾炎风险降低相关(OR 0.72,95%CI 0.54-0.98)。
  • HLA-C*12(OR 1.25,95%CI 0.97-1.62)和HLA-B*27/C*01(OR 1.40,95%CI 0.99-2.00)的关联较弱。
  • HLA-B*27与压痛指趾炎消退更慢相关(HR 0.74,95%CI 0.57-0.96)。

临床怎么用

  • 对PsA患者检测HLA-B*27和HLA-C*02可能有助于识别指趾炎高风险及消退较慢的个体。
  • HLA-B*27阳性指趾炎患者可能需要更密切的随访或更积极的治疗策略。

局限性

  • 研究结果为关联性发现,需要重复研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Human leukocyte antigen (HLA) alleles, particularly of HLA-B and HLA-C, are associated with the susceptibility to and the expression of psoriatic arthritis (PsA). We aimed to identify HLA alleles and haplotypes associated with dactylitis and the time to resolution of tender dactylitis. METHODS: We retrieved longitudinal data on 1216 patients with PsA followed at an observational cohort. We screened HLA-B and -C alleles with >5% frequency in our sample for association with dactylitis by employing logistic regression fitted using generalised estimating equations. We also analysed common haplotypes. We then used Cox regression, adjusted for confounders, to explore the association between these alleles and haplotypes with the time to resolution of the first tender dactylitis episode. RESULTS: Dactylitis was observed in 584 (48%) patients over a median follow-up of 12.0 years (IQR: 5.7-20.1). HLA-B*27 (odds ratio [OR] 1.94, 95% CI 1.49-2.53), HLA-C*02 (OR 1.63, 95% CI 1.17-2.25), and HLA-B*27/C*02 (OR 1.88, 95% CI 1.32-2.67) were associated with a higher risk of dactylitis, whereas HLA-B*15 was associated with a lower risk (OR 0.72, 95% CI 0.54-0.98). A weaker association was observed for HLA-C*12 (OR 1.25, 95% CI 0.97-1.62) and HLA-B*27/C*01 (OR 1.40, 95% CI 0.99-2.00). Notably, HLA-B*27 was associated with slower resolution of tender dactylitis (hazard ratio 0.74, 95% CI 0.57-0.96). CONCLUSIONS: HLA-B*27 and -C*02 and the HLA-B*27/C*02 haplotype are associated with PsA dactylitis. HLA-B*27 may also influence the resolution of tender dactylitis. These alleles are thus associated with PsA dactylitis susceptibility and severity; replication studies are required.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kharouf F, Abarza VC, Mehta P, et al. Psoriatic dactylitis: the association with HLA genetic susceptibility markers. Ann Rheum Dis. 2026. PMID: 41792024. doi:10.1016/j.ard.2026.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。